Selecting criteria for monitoring patients with rheumatoid arthritis

Joint Bone Spine

Volumn 72, Issue 2, 2005, Pages 129-134

  Soubrier, Martin ^a   Dougados, Maxime ^b  

^a SERVICE DE RHUMATOLOGIE   (France)

^b René Descartes University ^*  (France)

Author keywords

Disease activity; Functional impairment; Radiography; Rheumatoid arthritis

Indexed keywords

CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; DISEASE ACTIVITY; FOLLOW UP; FUNCTIONAL DISEASE; HUMAN; MORTALITY; RADIODIAGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; ARTHROGRAPHY; HEALTH STATUS; HEALTH SURVEY; HOSPITALIZATION; METHODOLOGY; PATHOPHYSIOLOGY; QUESTIONNAIRE; RADIOGRAPHY; TREATMENT OUTCOME;

ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; HEALTH STATUS; HUMANS; POPULATION SURVEILLANCE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 23844556281     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2004.05.007     Document Type: Short Survey

References (46)

1. D.L. Scott, C. Smith, K. Kaarela, and G. Kingsley Joint damage and disability in rheumatoid arthritis. An updated systematic review Clin Exp Rheum 21 Suppl 31 2003 S20 S27
2. K.W. Drossaers-Bakker, M. de Buck, D. van Zeben, A.H. Zwinderman, F.C. Breedveld, and J.M. Hazes Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time Arthritis Rheum 42 1999 1854 1860
3. F. Wolfe A reappraisal of HAQ disability in rheumatoid arthritis Arthritis Rheum 43 2000 2751 2761
4. E.T. Molenaar, A.E. Voskuyl, and B.A. Dijkmans Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission J Rheumatol 29 2002 267 270
5. D.M. van der Heijde Joint erosions and patients with early rheumatoid arthritis Br J Rheumatol 34 Suppl 2 1995 74 78
6. J.J. Goronzy, E.L. Matteson, J.W. Fulbright, K.J. Warrington, A. Chang-Miller, and G.G. Hunder Prognostic markers of radiographic progression in early rheumatoid arthritis Arthritis Rheum 50 2004 43 54
7. E. Lindqvist, K. Jonsson, T. Saxne, and K. Eberhardt Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis Ann Rheum Dis 62 2003 611 616
8. D.L. Scott Radiographs in rheumatoid arthritis Int J Adv Rheumatol 1 2003 2 9
9. D.L. Scott The diagnosis and prognosis of early arthritis: rationale for new prognostic criteria Arthritis Rheum 46 2002 286 290
10. 28 and change in radiological progression rate Arthritis Rheum 44 Suppl 2001 S175
11. A.A. Stenger, M.A. Van Leeuwen, P.M. Houtman, G.A. Bruyn, F. Speerstra, and B.C. Barendsen Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression Br J Rheumatol 37 1998 1157 1163
12. M.A. van Leeuwen, M.H. van Rijswijk, W.J. Sluiter, P.L. van Riel, I.H. Kuper, and L.B. van de Putte Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system J Rheumatol 24 1997 20 27
13. E.T. Molenaar, A.E. Voskuyl, H.J. Dinant, P.D. Bezemer, M. Boers, and B.A. Dijkmans Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission Arthritis Rheum 50 2004 36 42
14. S. Van Doornum, G. McColl, and I.P. Wicks Accelerated atherosclerosis. An extraarticular feature of rheumatoid arthritis Arthritis Rheum 46 2002 862 873
15. M.M. Ward Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs? Arthritis Rheum 44 2001 1467 1469
16. D.P.M. Symmons, M.A. Jones, D.L. Scott, and P. Prior Longterm mortality outcomes in patients with rheumatoid arthritis: early presenters continue to do well J Rheumatol 25 1998 1072 1077
17. F. Wolfe, D.M. Mitchell, J.T. Sibley, J.F. Fries, D.A. Bloch, and C.A. Williams The mortality of rheumatoid arthritis Arthritis Rheum 37 1994 481 494
18. N.J. Goodson, N.J. Wiles, M. Lunt, E.M. Barrett, A.J. Silman, and D.P. Symmons Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients Arthritis Rheum 46 2002 2010 2019
19. W. Koenig, M. Sund, M. Frolich, H.G. Fischer, H. Lowel, and A. Doring C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg study 1984 to 1992 Circulation 99 1999 237 242
20. P.M. Ridker, C.H. Hennikens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women New Engl J Med 342 2000 836 843
21. L.T.H. Jacobsson, C. Turesson, A. Gülfe, M. Cmkic, I.F. Petersson, and T. Saxne Low incidence of first cardiovascular event in rheumatoid arthritis patients treated with TNF-blockers Arthritis Rheum 48 Suppl 2003 S241
22. R. Clarke, L. Daly, K. Robinson, E. Naughten, S. Cahalane, and B. Fowler Hyperhomocysteinemia: an independent risk factor for vascular disease New Engl J Med 324 1991 1149 1155
23. A. Hernanz, A. Plaza, E. Martin-Mola, and E. de Miguel Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women Clin Biochem 32 1999 65 70
24. C.J. Haagsma, H.J. Blom, P.L. van Riel, M.A. van't Hof, B.A. Giesendorf, and D. van Oppenraaij-Emmerzaal Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis Ann Rheum Dis 8 1999 79 84
25. M.B. Lazarevic, J. Vitic, V. Mladenovic, B.L. Myones, J.L. Skosey, and W.I. Swedler Dyslipoproteinemia in the course of active rheumatoid arthritis Semin Arthritis Rheum 22 1992 172 178
26. M. Boers, M.T. Nurmohamed, C.J. Doelman, L.R. Lard, A.C. Verhoeven, and A.E. Voskuyl Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis Ann Rheum Dis 62 2003 842 845
27. Y.B. Park, S.K. Lee, W.K. Lee, C.H. Suh, C.W. Lee, and C.H. Lee Lipid profiles in untreated patients with rheumatoid arthritis J Rheumatol 26 1999 1701 1704
28. D.T. Felson, J.J. Anderson, M. Boers, C. Bombardier, D. Furst, and C. Goldsmith American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis Arthritis Rheum 38 1995 727 735
29. D.M.F.M. Van der Heijde, M.A. van't Hof, P.L.C.M. van Riel, H.A.M. Theunisse, E.W. Lubberts, and M.A. van Leeuwen Judging disease activity in clinical practice in rheumatoid arthritis. First step in the development of a 'disease activity score' Ann Rheum Dis 49 1990 916 920
30. D.M. Van der Heijde, M. van't Hof, P.L. van Riel, and L.B. van de Putte Development of a disease activity score based on judgment in clinical practice by rheumatologists J Rheumatol 20 1993 579 581
31. M.L. Prevoo, M.A. van't Hof, H.H. Kuper, M.A. van Leeuwen, L.B. van de Putte, and P.L. van Riel Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 1995 44 48
32. J. Fransen, P.M.J. Welsing, and R.M.H. De Keijzer Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity Ann Rheum 62 Suppl 1 2003 151
33. J.S. Smolen, F.C. Breedveld, M.H. Schiff, J.R. Kalden, P. Emery, and G. Eberl A simplified disease activity index for rheumatoid arthritis for use in clinical practice Rheumatology (Oxford) 42 2003 244 257
34. D.T. Felson, J.J. Anderson, M. Boers, C. Bombardier, M. Chernoff, and B. Fried The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials Arthritis Rheum 36 1993 729 740
35. A.M. Van Gestel, M.L.L. Preevo, M.A. van't Hof, M.H. van Rijswijk, L.B. van de Putte, and P.L.C.M. van Riel Development and validation of the European League against rheumatism response criteria for rheumatoid arthritis Arthritis Rheum 39 1996 34 40
36. R.S. Pinals, A.T. Masi, and R.A. Larsen Preliminary criteria for clinical remission in rheumatoid arthritis Arthritis Rheum 24 1981 1308 1315
37. M.L. Prevoo, A.M. van Gestel, M.A. van't Hof, M.H. van Rijswijk, L.B. van de Putte, and P.L. van Riel Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score Br J Rheumatol 35 1996 1101 1105
38. 28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis J Rheumatol 31 2004 40 46
39. J.T. Sharp, D.Y. Young, G.B. Bluhm, A. Brook, A.C. Brower, and M. Corbett How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 28 1985 1326 1335
40. D. van der Heijde How to read radiographs according to the Sharp/van der Heijde method J Rheumatol 26 1999 743 745
41. A. Larsen How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies J Rheumatol 22 1995 1974 1975
42. K. Bruynesteyn, D. van der Heijde, M. Boers, A. Saudan, P. Peloso, and H. Paulus Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference Arthritis Rheum 46 2002 913 920
43. V. Strand, and J.T. Sharp Radiographic data from recent randomized controlled trials in rheumatoid arthritis: what have we learned? Arthritis Rheum 48 2003 21 34
44. F. Guillemin, S. Briançon, and J. Pourel Mesure de la capacité fonctionnelle dans la polyarthrite rhumatoïde: Adaptation française du Health Assessment Questionnaire [HAQ] Rev Rhum 58 1991 459 465
45. D.R. Porter, C. Grigor, A. Stirling, and H.A. Capell A randomised controlled trial of a strategy of tight control of disease activity in rheumatoid arthritis-outcome over 18 months Arthritis Rheum 48 Suppl 2003 S232
46. D.W. McCarey, N. Sattar, R. Hampson, R. Madhok, A. Capell, and I.B. McInnes A randomized placebo controlled trial comparing the anti-inflammatory and vascular risk modulatory effects of Atorvastatin in rheumatoid arthritis Arthritis Rheum 48 Suppl 2003 S666